Before the Minister sits down and before my noble friend responds, perhaps I may ask the Minister this question. Let us suppose that, in the light of the developments and proposals that he has outlined, the insurance industry—the ABI—decides, in the goodness of its heart and bearing in mind the importance of this problem, that it wishes to make an ongoing and regular contribution to research in this field. Would the National Institute for Health Research be precluded from accepting non-government funds or would such funding have to be channelled, for example, through the cancer research campaign?
Mesothelioma Bill [HL]
Proceeding contribution from
Lord Walton of Detchant
(Crossbench)
in the House of Lords on Wednesday, 17 July 2013.
It occurred during Debate on bills on Mesothelioma Bill [HL].
Type
Proceeding contribution
Reference
747 c787 
Session
2013-14
Chamber / Committee
House of Lords chamber
Librarians' tools
Timestamp
2013-12-20 03:58:49 +0000
URI
http://hansard.intranet.data.parliament.uk/Lords/2013-07-17/13071782000014
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2013-07-17/13071782000014
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2013-07-17/13071782000014